GSK spin-off raises $35.4 million
Convergence Pharmaceuticals, a company launched with assets from GlaxoSmithKline (GSK), has raised $35.4 million (£22.4 million) from three investors.
News
Convergence Pharmaceuticals, a company launched with assets from GlaxoSmithKline (GSK), has raised $35.4 million (£22.4 million) from three investors.
News